TRPV1 and acute myeloid leukemia: Similarly, in the TARGET-AML dataset, TRPV1 expression was significantly increased in pediatric AML patients at diagnosis (P < 0.0001) and relapse (P < 0.0007) compared to healthy subjects (Fig. 1B).